Lynda Cristiano Email Address

Vice President; Therapeutic Area Head Rare Blood Disorders

Bioverativ is a global biotechnology company dedicated to transforming the lives of people living with hemophilia and other blood disorders.

US-trained and licensed physician with 14 years of extensive experience in pharmacovigilance and benefit-risk management. Broad experience with a risk management system for a product with a complex distribution system with elements to assure safe use; presented risk management learning to regulatory authorities, and led teams to successful completion of a global phase IV observational program and pregnancy registry. Highly effective executive with excellent leadership and communication skills and a proven track record of success in providing strategic leadership in the development of risk management plans, global filings, new drug approvals, and product launches in the rare disease therapeutic area. Responsible for providing strategic input for clinical studies throughout product development: phase 1/2a, phase 3, and phase 4 observational studies, and critical assessment of post marketing data. Currently Vice President, Therapeutic Area Head of Pharmacovigilance, Rare Blood Disorders having led the effective transition of pharmacovigilance from a parent company, built a world-class pharmacovigilance organization, now successfully transitioning to a new leadership role post company acquisition.